Categories
Topics

Smart Nanoparticles keep immunotherapy focused on cancer

Deactivate selection mode Select images

The selection mode is now active. Click on the images you wish to download and choose an action below

MIT and EPFL researchers have developed a highly targeted and non-toxic method for battling cancer through immunotherapy. Their nanoparticle gel acts only on immune cells surrounding the tumor, without affecting the rest of the body. The research project began at MIT and was completed at EPFL, in the Laboratory of Biomaterials for Immunoengineering (LBI), headed by Li Tang in the School of Engineering (STI). MIT and EPFL researchers have developed a highly targeted and non-toxic method for battling cancer through immunotherapy. Their nanoparticle gel acts only on immune cells surrounding the tumor, without affecting the rest of the body. The research project began at MIT and was completed at EPFL, in the Laboratory of Biomaterials for Immunoengineering (LBI), headed by Li Tang in the School of Engineering (STI). MIT and EPFL researchers have developed a highly targeted and non-toxic method for battling cancer through immunotherapy. Their nanoparticle gel acts only on immune cells surrounding the tumor, without affecting the rest of the body. The research project began at MIT and was completed at EPFL, in the Laboratory of Biomaterials for Immunoengineering (LBI), headed by Li Tang in the School of Engineering (STI). MIT and EPFL researchers have developed a highly targeted and non-toxic method for battling cancer through immunotherapy. Their nanoparticle gel acts only on immune cells surrounding the tumor, without affecting the rest of the body. The research project began at MIT and was completed at EPFL, in the Laboratory of Biomaterials for Immunoengineering (LBI), headed by Li Tang in the School of Engineering (STI).